Annual ‘top 10 drugs’
December 3, 2013
In the latest edition of Australian
Prescriber, off-label prescribing
and drug therapies for anxiety are
discussed as well as the annual lists
of the top 10 subsidised drugs by
daily dose per 1000 population per
day, by prescription count, and by
cost to government.
Atorvastatin, marketed as Lipitor
by Pfizer and now genericised,
heads up all three lists with proton
pump inhibitors, pain relievers,
ACE inhibitors, diabetes, asthma
and blood pressure medicines also
appearing in the list of top 10 drugs
by number of prescriptions.
Other topics include the new
diabetes therapies.
CLICK HERE to read in full.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Dec 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Dec 13